Bortezomib therapy has proven successful for the treatment of relapsed and/or refractory
multiple myeloma (MM); however, prolonged treatment is associated with toxicity and …

Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only
a small subset of these cells generates metastases. We conducted an in vivo genome-wide …

Bortezomib therapy has proven successful for the treatment of relapsed/refractory, relapsed,
and newly diagnosed multiple myeloma (MM); however, dose-limiting toxicities and the …

The diketopiperazine NPI-2358 is a synthetic analog of NPI-2350, a natural product isolated
from Aspergillus sp., which depolymerizes microtubules in A549 human lung carcinoma …

Recent technological advances—new pathophysiological insights, new imaging techniques
for diagnosis and management, and new treatments—have led to an improved …

Converting lead compounds into drug candidates is a crucial step in drug development,
requiring early assessment of potency, selectivity, and off-target effects. We have utilized activity-…

Background Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age
population worldwide. Many observational and preclinical studies have implicated vascular …

Mice transgenic for the Polyomavirus middle T (PyV-mT) gene have been widely used to
study mammary tumorigenesis and metastasis. Although numerous molecular insights were …

The deubiquitylating enzyme USP7 (HAUSP) sits at a critical node regulating the activities
of numerous proteins broadly characterized as tumor suppressors, DNA repair proteins, …

The aberrant production of nitric oxide (NO) contributes to the pathogenesis of diseases as
diverse as cancer and arthritis. Sustained NO production via the inducible enzyme, nitric-…